X0508 4 2026-01-27 0001719406 NRX Pharmaceuticals, Inc. NRXP 0002106955 Casper Joseph Michael C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600 WILMINGTON DE 19801 1 Chief Operating Officer 0 Stock Option (right to buy) 2.39 2026-01-27 4 A 0 100000 0 A 2036-01-27 Common Stock 100000 100000 D Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. 33.3% of the Options shall vest on June 1, 2026, 33.3% shall vest on December 1, 2026, and the remaining 33.3% shall vest on December 1, 2027. /s/ Joseph M. Casper 2026-02-17